These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance. Wiest R; Groszmann RJ Semin Liver Dis; 1999; 19(4):411-26. PubMed ID: 10643626 [TBL] [Abstract][Full Text] [Related]
6. Exercise-induced splanchnic hypoperfusion results in gut dysfunction in healthy men. van Wijck K; Lenaerts K; van Loon LJ; Peters WH; Buurman WA; Dejong CH PLoS One; 2011; 6(7):e22366. PubMed ID: 21811592 [TBL] [Abstract][Full Text] [Related]
7. Abdominal contributions to cardiorenal dysfunction in congestive heart failure. Verbrugge FH; Dupont M; Steels P; Grieten L; Malbrain M; Tang WH; Mullens W J Am Coll Cardiol; 2013 Aug; 62(6):485-95. PubMed ID: 23747781 [TBL] [Abstract][Full Text] [Related]
8. Protein-bound uremic toxins - biological effects and impact on morbidity in patients with chronic kidney disease. Gomółka M; Niemczyk S Przegl Lek; 2017; 74(3):110-4. PubMed ID: 29694770 [TBL] [Abstract][Full Text] [Related]
9. Splanchnic circulation and metabolism in patients with acute liver failure. Clemmesen O Dan Med Bull; 2002 Aug; 49(3):177-93. PubMed ID: 12238280 [TBL] [Abstract][Full Text] [Related]
10. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development. Briskey D; Tucker P; Johnson DW; Coombes JS Clin Exp Nephrol; 2017 Feb; 21(1):7-15. PubMed ID: 26965149 [TBL] [Abstract][Full Text] [Related]
11. Exploring binding characteristics and the related competition of different protein-bound uremic toxins. Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271 [TBL] [Abstract][Full Text] [Related]
12. Hemodynamic changes in splanchnic blood vessels in portal hypertension. Colle I; Geerts AM; Van Steenkiste C; Van Vlierberghe H Anat Rec (Hoboken); 2008 Jun; 291(6):699-713. PubMed ID: 18484617 [TBL] [Abstract][Full Text] [Related]
13. [Uremic toxins and gut micro biome]. Vaziri ND; Suematsu Y; Shimomura A; Vaziri ND Nihon Jinzo Gakkai Shi; 2017; 59(4):535-544. PubMed ID: 30620802 [TBL] [Abstract][Full Text] [Related]
14. Circulating Bacterial Fragments as Cardiovascular Risk Factors in CKD. Szeto CC; McIntyre CW; Li PK J Am Soc Nephrol; 2018 Jun; 29(6):1601-1608. PubMed ID: 29666156 [TBL] [Abstract][Full Text] [Related]
15. Platelet activating factor mediates systemic circulatory collapse after temporary hepatic inflow occlusion. Fukuoka T; Nakajima Y; Horikawa M; Aomatsu Y; Yoshimura A; Ueno M; Ko S; Nakano H Transplant Proc; 1993 Apr; 25(2):1809-10. PubMed ID: 8470175 [No Abstract] [Full Text] [Related]
16. Spontaneous variability of pre-dialysis concentrations of uremic toxins over time in stable hemodialysis patients. Eloot S; Van Biesen W; Roels S; Delrue W; Schepers E; Dhondt A; Vanholder R; Glorieux G PLoS One; 2017; 12(10):e0186010. PubMed ID: 29016645 [TBL] [Abstract][Full Text] [Related]
17. Splanchnic oxygen transport, hepatic function and gastrointestinal barrier after normothermic cardiopulmonary bypass. Braun JP; Schroeder T; Buehner S; Dohmen P; Moshirzadeh M; Grosse J; Streit F; Schlaefke A; Armstrong VW; Oellerich M; Lochs H; Konertz W; Kox WJ; Spies C Acta Anaesthesiol Scand; 2004 Jul; 48(6):697-703. PubMed ID: 15196101 [TBL] [Abstract][Full Text] [Related]